We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

4SC Expands Patent Protection for Epigenetic Anti-Cancer Compound

News   Jul 15, 2013

 
4SC Expands Patent Protection for Epigenetic Anti-Cancer Compound
 
 
Advertisement
 

RELATED ARTICLES

Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection

News

A Phase III, randomized, double-blinded, placebo-controlled trial will help to determine if the dual-antibody treatment, REGN-COV2, can prevent infection in individuals who share a home with someone who has been diagnosed with COVID-19.

READ MORE

University of New Hampshire Awarded $1.8 M To Explore Drug Interactions and Targeted Drug Development

News

The University of New Hampshire is set to receive $1.8 million from the National Institutes of Health. This will be used to further the university's research to better understand drug interactions at the cellular level and help develop new targeted drugs to treat disorders including diabetes and cancer.

READ MORE

Circular RNA Molecule ciRS-7 Not Found in Cancer Cells After All

News

New research from Aarhus University shows that a circular RNA molecule, which has been designated as carcinogenic, is actually not found in the cancer cells. Researchers suggest that the molecule contributes to the development of cancer through what is known as the microenvironment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE